No Data
T2 Biosystems Sells Four T2Dx Instruments To Existing European Distributor; Amount Not Disclosed
T2 Biosystems Announces Sale of Four T2Dx Instruments to Existing European Distributor
T2 Biosystems Achieves Milestone With 250,000th Novel Sepsis Test Shipped
T2 Biosystems Achieves Key Milestone With 250,000th Novel Sepsis Test Shipped Globally
T2 Biosystems Announces Extension of Multi-Year Capital Equipment Supplier Agreement With Vizient, Inc.
T2 Biosystems Announces Plans to License Its Proprietary Technology to Expand Its Leadership in Direct-From-Whole-Blood Detection of Sepsis-Causing Pathogens
No Data
